1. Home
  2. HALO vs VSAT Comparison

HALO vs VSAT Comparison

Compare HALO & VSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

N/A

Current Price

$107.93

Market Cap

12.0B

Sector

Health Care

ML Signal

N/A

Logo ViaSat Inc.

VSAT

ViaSat Inc.

N/A

Current Price

$70.25

Market Cap

9.6B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
HALO
VSAT
Founded
1998
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
12.0B
9.6B
IPO Year
2001
1996

Fundamental Metrics

Financial Performance
Metric
HALO
VSAT
Price
$107.93
$70.25
Analyst Decision
Buy
Buy
Analyst Count
9
11
Target Price
$99.56
★ $103.94
AVG Volume (30 Days)
★ 2.0M
1.4M
Earning Date
11-02-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 94.42
EPS
★ 3.11
N/A
Revenue
★ $151,862,000.00
N/A
Revenue This Year
$32.72
$4.53
Revenue Next Year
$10.61
$4.59
P/E Ratio
$36.16
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$61.23
$29.13
52 Week High
$116.85
$93.03

Technical Indicators

Market Signals
Indicator
HALO
VSAT
Relative Strength Index (RSI) 54.81 40.44
Support Level $104.49 $67.16
Resistance Level $111.15 $77.90
Average True Range (ATR) 3.04 3.34
MACD -0.71 -0.41
Stochastic Oscillator 42.53 6.12

Price Performance

Historical Comparison
HALO
VSAT

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About VSAT ViaSat Inc.

Viasat Inc an world-wide provider of communications technologies and services, focused on making connectivity accessible, available and secure for current and future customers world-wide. The company has two reportable segments: communication services and defense and advanced technologies. It generates majority of revenue from communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers. It has presence in United States and Outside United States. The company generates majority of revenue from United States. Its products are Antennas, Terminals & radios, Modems, Semiconductors, Cybersecurity, Software & services, Home internet.

Share on Social Networks: